14-day Premium Trial Subscription Try For FreeTry Free
$23.03
+0.570 (+2.54%)
At Close: May 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
May 02, 2024 Sell 4 745 Valente Nancy Common Stock
Apr 09, 2024 Buy 190 194 Cornelissen Bart Jan Stock Option (Right to Buy)
Apr 09, 2024 Buy 42 265 Cornelissen Bart Jan Common Stock
Apr 09, 2024 Buy 0 Cornelissen Bart Jan
Mar 11, 2024 Sell 849 Kuch John J Common Stock
Mar 11, 2024 Sell 850 Eckert Celia Common Stock
Mar 11, 2024 Sell 1 280 Desjarlais John R Common Stock
Mar 11, 2024 Sell 2 741 Dahiyat Bassil I Common Stock
Mar 06, 2024 Buy 15 000 Gustafson Kurt A Common Stock
Mar 06, 2024 Sell 14 000 Gustafson Kurt A Common Stock
Mar 06, 2024 Sell 15 000 Gustafson Kurt A Stock Option (Right to Buy)
Mar 05, 2024 Buy 117 801 Valente Nancy Stock Options
Mar 05, 2024 Buy 19 634 Valente Nancy Common Stock
Mar 05, 2024 Sell 4 474 Kuch John J Common Stock
Mar 05, 2024 Buy 20 724 Desjarlais John R Common Stock
Mar 05, 2024 Sell 6 629 Desjarlais John R Common Stock
Mar 05, 2024 Buy 124 346 Desjarlais John R Stock Options
Mar 05, 2024 Buy 78 534 Eckert Celia Stock Options
Mar 05, 2024 Buy 13 089 Eckert Celia Common Stock
Mar 05, 2024 Sell 3 892 Eckert Celia Common Stock
Mar 05, 2024 Buy 54 538 Dahiyat Bassil I Common Stock
Mar 05, 2024 Buy 327 225 Dahiyat Bassil I Stock Options
Mar 05, 2024 Sell 12 528 Dahiyat Bassil I Common Stock
Feb 14, 2024 Buy 11 943 Desjarlais John R Common Stock
Feb 14, 2024 Sell 11 943 Desjarlais John R Stock Option (Right to Buy)
Feb 13, 2024 Buy 53 Gorman Kevin Charles Common Stock
Feb 13, 2024 Buy 68 057 Desjarlais John R Common Stock
Feb 13, 2024 Sell 54 108 Desjarlais John R Common Stock
Feb 13, 2024 Sell 68 057 Desjarlais John R Stock Option (Right to Buy)
Dec 29, 2023 Buy 65 001 Dahiyat Bassil I Common Stock
Dec 29, 2023 Sell 45 000 Dahiyat Bassil I Common Stock
Dec 29, 2023 Sell 65 001 Dahiyat Bassil I Stock Option (Right to Buy)
Sep 15, 2023 Buy 40 070 Klencke Barbara Stock Option (Right to Buy)
Sep 15, 2023 Buy 0 Klencke Barbara
Jun 21, 2023 Buy 76 012 Dahiyat Bassil I Common Stock
Jun 21, 2023 Sell 33 497 Dahiyat Bassil I Common Stock
Jun 21, 2023 Sell 76 012 Dahiyat Bassil I Stock Option (Right to Buy)
Jun 20, 2023 Buy 10 013 Gustafson Kurt A Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Gustafson Kurt A Common Stock
Jun 20, 2023 Buy 10 013 Gorman Kevin Charles Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Gorman Kevin Charles Common Stock
Jun 20, 2023 Buy 10 013 Feigal Ellen Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Feigal Ellen Common Stock
Jun 20, 2023 Buy 10 013 Rosa-bjorkeson Dagmar Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Rosa-bjorkeson Dagmar Common Stock
Jun 20, 2023 Buy 10 013 Montgomery Alan Bruce Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Montgomery Alan Bruce Common Stock
Jun 20, 2023 Buy 10 013 Ranieri Richard J Stock Option (Right to Buy)
Jun 20, 2023 Buy 5 007 Ranieri Richard J Common Stock
Jun 20, 2023 Buy 10 013 Ranieri Richard J Stock Options
Jun 20, 2023 Buy 5 007 Ranieri Richard J Common Stock
May 01, 2023 Buy 235 778 Valente Nancy Stock Options
May 01, 2023 Buy 39 296 Valente Nancy Common Stock
Mar 09, 2023 Sell 1 094 Yang Allen Common Stock
Mar 09, 2023 Sell 711 Eckert Celia Common Stock
Mar 09, 2023 Sell 711 Kuch John J Common Stock
Mar 09, 2023 Sell 1 230 Desjarlais John R Common Stock
Mar 09, 2023 Sell 2 602 Dahiyat Bassil I Common Stock
Mar 06, 2023 Sell 4 069 Yang Allen Common Stock
Mar 06, 2023 Sell 2 774 Kuch John J Common Stock
Mar 06, 2023 Sell 2 462 Eckert Celia Common Stock
Mar 06, 2023 Sell 4 195 Desjarlais John R Common Stock
Mar 06, 2023 Sell 5 831 Dahiyat Bassil I Common Stock
Mar 03, 2023 Sell 2 851 Dahiyat Bassil I Common Stock
Mar 03, 2023 Sell 919 Kuch John J Common Stock
Mar 03, 2023 Sell 427 Eckert Celia Common Stock
Mar 03, 2023 Sell 1 232 Desjarlais John R Common Stock
Mar 02, 2023 Buy 315 126 Dahiyat Bassil I Stock Options
Mar 02, 2023 Buy 52 521 Dahiyat Bassil I Common Stock
Mar 02, 2023 Buy 12 005 Kuch John J Common Stock
Mar 02, 2023 Buy 72 029 Kuch John J Stock Options
Mar 02, 2023 Buy 63 025 Eckert Celia Stock Options
Mar 02, 2023 Buy 10 504 Eckert Celia Common Stock
Mar 02, 2023 Buy 90 036 Yang Allen Stock Options
Mar 02, 2023 Buy 15 006 Yang Allen Common Stock
Mar 02, 2023 Buy 18 758 Desjarlais John R Common Stock
Mar 02, 2023 Buy 112 545 Desjarlais John R Stock Options
Dec 31, 2022 Buy 0 Kuch John J
Dec 19, 2022 Sell 3 737 Yang Allen Common Stock
Sep 08, 2022 Buy 35 282 Valente Nancy Stock Option (Right to Buy)
Sep 08, 2022 Buy 0 Valente Nancy
Jun 23, 2022 Buy 21 412 Hata Yujiro S Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Gustafson Kurt A Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Gustafson Kurt A Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Gorman Kevin Charles Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Gorman Kevin Charles Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Rosa-bjorkeson Dagmar Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Ranieri Richard J Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Ranieri Richard J Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Montgomery Alan Bruce Stock Option (Right to Buy)
Jun 23, 2022 Buy 21 412 Feigal Ellen Stock Option (Right to Buy)
Mar 09, 2022 Sell 1 200 Yang Allen Common Stock
Mar 09, 2022 Sell 690 Kuch John J Common Stock
Mar 09, 2022 Sell 789 Eckert Celia Common Stock
Mar 09, 2022 Sell 1 172 Desjarlais John R Common Stock
Mar 09, 2022 Sell 2 494 Dahiyat Bassil I Common Stock
Mar 03, 2022 Buy 66 348 Yang Allen Stock Options
Mar 03, 2022 Buy 23 222 Kuch John J Common Stock
Mar 03, 2022 Sell 971 Kuch John J Common Stock
Mar 03, 2022 Buy 46 444 Kuch John J Stock Options
JSON CSV
INSIDER POWER
63.753
Last 100 transactions
Buy: 2 791 671 | Sell: 462 767 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 63.753.

In total, the insiders bought 2 791 671 and sold 462 767 XNCR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Xencor

Xencor Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with r... XNCR Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT